These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 15349138)

  • 1. Genomics and phenotypic profiles in dementia: implications for pharmacological treatment.
    Cacabelos R; Fernández-Novoa L; Corzo L; Pichel V; Lombardi V; Kubota Y
    Methods Find Exp Clin Pharmacol; 2004; 26(6):421-44. PubMed ID: 15349138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic characterization of Alzheimer's disease and genotype-related phenotypic analysis of biological markers in dementia.
    Cacabelos R
    Pharmacogenomics; 2004 Dec; 5(8):1049-105. PubMed ID: 15584876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotypic profiles and functional genomics in Alzheimer's disease and in dementia with a vascular component.
    Cacabelos R; Fernández-Novoa L; Corzo L; Amado L; Pichel V; Lombardi V; Kubota Y
    Neurol Res; 2004 Jul; 26(5):459-80. PubMed ID: 15265264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular pathology and pharmacogenomics in Alzheimer's disease: polygenic-related effects of multifactorial treatments on cognition, anxiety and depression.
    Cacabelos R
    Methods Find Exp Clin Pharmacol; 2007 Jul; 29 Suppl A():1-91. PubMed ID: 17957277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacogenomics in Alzheimer's disease.
    Cacabelos R
    Methods Mol Biol; 2008; 448():213-357. PubMed ID: 18370236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of pharmacogenetic factors on Alzheimer's disease therapeutics.
    Cacabelos R
    Neurodegener Dis; 2008; 5(3-4):176-8. PubMed ID: 18322383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The application of functional genomics to Alzheimer's disease.
    Cacabelos R
    Pharmacogenomics; 2003 Sep; 4(5):597-621. PubMed ID: 12943467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic risk profiles for Alzheimer's disease: integration of APOE genotype and variants that up-regulate inflammation.
    Licastro F; Porcellini E; Caruso C; Lio D; Corder EH
    Neurobiol Aging; 2007 Nov; 28(11):1637-43. PubMed ID: 16930778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ACE I/D polymorphism is a risk factor of Alzheimer's disease but not of vascular dementia.
    Kölsch H; Jessen F; Freymann N; Kreis M; Hentschel F; Maier W; Heun R
    Neurosci Lett; 2005 Mar; 377(1):37-9. PubMed ID: 15722183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of depression with Alzheimer's disease and vascular dementia in an elderly Arab population of Wadi-Ara, Israel.
    Bowirrat A; Oscar-Berman M; Logroscino G
    Int J Geriatr Psychiatry; 2006 Mar; 21(3):246-51. PubMed ID: 16477584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein E genotypes in hospitalized elderly patients with vascular dementia.
    Orsitto G; Seripa D; Panza F; Franceschi M; Cascavilla L; Placentino G; Matera MG; Paris F; Capurso C; Solfrizzi V; Dallapiccola B; Pilotto A
    Dement Geriatr Cogn Disord; 2007; 23(5):327-33. PubMed ID: 17374951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacogenomics and therapeutic strategies for dementia.
    Cacabelos R
    Expert Rev Mol Diagn; 2009 Sep; 9(6):567-611. PubMed ID: 19732004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacogenomics and therapeutic prospects in dementia.
    Cacabelos R
    Eur Arch Psychiatry Clin Neurosci; 2008 Mar; 258 Suppl 1():28-47. PubMed ID: 18344047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deletion/insertion polymorphism of the angiotensin-converting enzyme gene and white matter hyperintensities in dementia: A pilot study.
    Purandare N; Oude Voshaar RC; Davidson Y; Gibbons L; Hardicre J; Byrne J; McCollum C; Jackson A; Burns A; Mann DM
    J Am Geriatr Soc; 2006 Sep; 54(9):1395-400. PubMed ID: 16970648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain interleukin-1 beta in Alzheimer's disease and vascular dementia.
    Cacabelos R; Alvarez XA; Fernández-Novoa L; Franco A; Mangues R; Pellicer A; Nishimura T
    Methods Find Exp Clin Pharmacol; 1994 Mar; 16(2):141-51. PubMed ID: 8007743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. APOE-related frequency of cognitive and noncognitive symptoms in dementia.
    Cacabelos R; Rodríguez B; Carrera C; Caamaño J; Beyer K; Lao JI; Sellers MA
    Methods Find Exp Clin Pharmacol; 1996 Dec; 18(10):693-706. PubMed ID: 9121226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular factors and markers of inflammation in offspring with a parental history of late-onset Alzheimer disease.
    van Exel E; Eikelenboom P; Comijs H; Frölich M; Smit JH; Stek ML; Scheltens P; Eefsting JE; Westendorp RG
    Arch Gen Psychiatry; 2009 Nov; 66(11):1263-70. PubMed ID: 19884614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Convergence of genes implicated in Alzheimer's disease on the cerebral cholesterol shuttle: APP, cholesterol, lipoproteins, and atherosclerosis.
    Carter CJ
    Neurochem Int; 2007 Jan; 50(1):12-38. PubMed ID: 16973241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing cerebrovascular contribution to late dementia of the Alzheimer's type: the role of combined hemodynamic and structural MR analysis.
    Henry-Feugeas MC
    J Neurol Sci; 2009 Aug; 283(1-2):44-8. PubMed ID: 19268312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anatomically-distinct genetic associations of APOE epsilon4 allele load with regional cortical atrophy in Alzheimer's disease.
    Filippini N; Rao A; Wetten S; Gibson RA; Borrie M; Guzman D; Kertesz A; Loy-English I; Williams J; Nichols T; Whitcher B; Matthews PM
    Neuroimage; 2009 Feb; 44(3):724-8. PubMed ID: 19013250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.